---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-002421"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:12:24.747693+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tharimmune receives Nasdaq noncompliance notice for board independence; plans cure at Jan 30 meeting

## Summary
- Nasdaq notified Tharimmune on Jan 9, 2026 of noncompliance with Listing Rule 5605 (majority independent directors) following resignations of Nancy Davis and Sanam Parikh effective Nov 6, 2025.
- Cure period ends on earlier of next annual shareholders' meeting or Nov 6, 2026; if annual meeting before May 5, 2026, then May 5, 2026.
- Company will seek shareholder approval at a special meeting on Jan 30, 2026 to elect two additional independent directors to the Board.
- After the special meeting, the Company expects a majority of its Board to be independent, regaining compliance.

## SEC filing metadata
- accession: 0001493152-26-002421
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315226002421/0001493152-26-002421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315226002421/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-002421
- JSON: https://secwatch.observer/filing/0001493152-26-002421.json
- Plain text: https://secwatch.observer/filing/0001493152-26-002421.txt

## Key facts
- Listing & Compliance Notices
  Canton Strategic Holdings, Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: board independence
  - Rules: 5605
  source text: January 9, 2026, Tharimmune, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq Listing Rule 5605 (“Rule 5605”), which requires, among other things, that a majority of the Board of Directors of the Company (the “Board”) be comprised of independent directors. As previously disclosed, Nancy Davis and Sanam Parikh resigned as members of the Board, effective as of November 6, 2025 and Mark Wendland was elected to replace Sanam Parikh, resulting in one vacancy on the Board and the noncompliance. In accordance with Nasdaq List
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000149315226002421/0001493152-26-002421-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.